Sexually transmitted disease (STD) testing market size to grow by USD 29,988.27 Million: Increasing prevalence of STDs remains key growth driver - Technavio
NEW YORK, Dec. 7, 2022 /PRNewswire/ -- The global sexually transmitted disease (STD) testing market size is set to grow by USD 29,988.27 million from 2022 to 2027, according to Technavio. The growth momentum of the market will accelerate at a CAGR of 5.46% during the forecast period. This report provides analysis and insights to enable effective decision-making. Download A Sample Report
Sexually transmitted disease (STD) testing market - Key Driver and Major Challenge
The increasing prevalence of STDs is driving the sexually transmitted disease (STD) testing market growth. The prevalence of various types of STDs has increased globally. For instance, in 2020, 0.7% of the global population aged 15-49 years was diagnosed with HIV. The prevalence of the condition is high in low and middle-income countries. Sub-Saharan Africa and Asia-Pacific are some of the regions that are majorly affected by the disease. The rising prevalence of many such STDs is increasing the demand for early screening and diagnosis to reduce the chances of mortality. All these factors are driving the growth of the global sexually transmitted disease (STD) testing market.
The limited healthcare service in developing regions is impeding the sexually transmitted disease (STD) testing market growth. A majority of the population in developing countries are either unaware or have less access to proper healthcare facilities. This is due to the lack of financial and human resources in medical care, which limits the reach of proper healthcare services to the public. Some countries such as Kenya, Algeria, Afghanistan, and Bangladesh lack technology, infrastructure, and adequate policies to ensure efficient healthcare service delivery. Moreover, the lack of education and the social stigma associated with STDs avoids people in such countries to undergo screening for sexually transmitted diseases. All these factors are reducing the growth potential in the market.
Technavio has identified key trends, drivers, and challenges, along with competitive analysis to help clients improve their strategies to stay ahead of their competitors. Buy the reportto obtain detailed insights about the market.
Major five sexually transmitted disease (STD) testing companies
AccuBioTech Co. Ltd. - The company offers Accu-tell Gonorrhea Rapid test cassette which is designed for the visual detection of gonococcus infection.
AdvaCare Pharma - The company offers vaginal pH test kit which is designed to measure the vagina pH of the cervical mucus.
BIOGENIX Inc. Pvt. Ltd. - The company offers Scrub Typhus IgM Rapid Test which is designed for the detection of Immunoglobulin M.
F. Hoffmann La Roche Ltd. - The company offers cobas TV/MG test which is designed detection of Trichomonas vaginalis and Mycoplasma genitalium DNA in male and female urine.
Gilead Sciences Inc. - The company offers once daily oral Truvad, in combination with safer sex practices which is designed to reduce the risk of sexually acquired HIV 1 infection in adults at high risk.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report
What are the key data covered in this sexually transmitted disease (STD) testing market report?
CAGR of the market during the forecast period.
Detailed information on factors that will drive the growth of the market between 2023 and 2027
Precise estimation of the size of the sexually transmitted disease (STD) testing market and its contribution to the parent market.
Accurate predictions about upcoming trends and changes in consumer behavior.
Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW).
A thorough analysis of the market's competitive landscape and detailed information about vendors.
Comprehensive analysis of factors that will challenge the growth of sexually transmitted disease (STD) testing market vendors.
Related Reports
The medical diagnostics market is estimated to grow at a CAGR of 6.15% between 2022 and 2027. The size of the market is forecast to increase by USD 74.58 billion. The high prevalence of infectious diseases is notably driving the market growth, although factors such as the lack of trained laboratory technicians may impede the market growth.
The toxicology testing market is estimated to grow at a CAGR of 15.09% between 2022 and 2027. The size of the market is forecast to increase by USD 27.5 billion. The rise in toxicology testing in the food industry is notably driving the market growth, although factors such as a lack of skilled professionals may impede the market growth.
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 47%
Key countries
US, Canada, Germany, UK, and China
Competitive landscape
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled
AbbVie Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt. Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Goffin Molecular Technologies, Hangzhou Biotest Biotech Co. Ltd., Hologic Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, LT Labs, Merck and Co. Inc., OK Biotech Co. Ltd., Priority STD Testing, QIAGEN NV, and RayBiotech Life Inc.
Market dynamics
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table of contents:
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary ? Chart on Market Overview
Exhibit 02: Executive Summary ? Data Table on Market Overview
Exhibit 03: Executive Summary ? Chart on Global Market Characteristics
Exhibit 04: Executive Summary ? Chart on Market by Geography
Exhibit 05: Executive Summary ? Chart on Market Segmentation by Disease Type
Exhibit 06: Executive Summary ? Chart on Market Segmentation by Product
Exhibit 07: Executive Summary ? Chart on Incremental Growth
Exhibit 08: Executive Summary ? Data Table on Incremental Growth
Exhibit 09: Executive Summary ? Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on POC testing device - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Product
Exhibit 67: Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 69: Chart on Market share by geography 2022-2027 (%)
Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 105: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 109: Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption
11.4 Industry risks
Exhibit 113: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 114: Vendors covered
12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 116: AbbVie Inc. - Overview
Exhibit 117: AbbVie Inc. - Product / Service
Exhibit 118: AbbVie Inc. - Key offerings
12.4 AccuBioTech Co. Ltd.
Exhibit 119: AccuBioTech Co. Ltd. - Overview
Exhibit 120: AccuBioTech Co. Ltd. - Product / Service
Exhibit 121: AccuBioTech Co. Ltd. - Key offerings
12.5 AdvaCare Pharma
Exhibit 122: AdvaCare Pharma - Overview
Exhibit 123: AdvaCare Pharma - Product / Service
Exhibit 124: AdvaCare Pharma - Key offerings
12.6 BIOGENIX Inc. Pvt. Ltd.
Exhibit 125: BIOGENIX Inc. Pvt. Ltd. - Overview
Exhibit 126: BIOGENIX Inc. Pvt. Ltd. - Product / Service
Exhibit 127: BIOGENIX Inc. Pvt. Ltd. - Key offerings
12.7 F. Hoffmann La Roche Ltd.
Exhibit 128: F. Hoffmann La Roche Ltd. - Overview
Exhibit 129: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 130: F. Hoffmann La Roche Ltd. - Key news
Exhibit 131: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 132: F. Hoffmann La Roche Ltd. - Segment focus
12.8 Gilead Sciences Inc.
Exhibit 133: Gilead Sciences Inc. - Overview
Exhibit 134: Gilead Sciences Inc. - Product / Service
Exhibit 135: Gilead Sciences Inc. - Key news
Exhibit 136: Gilead Sciences Inc. - Key offerings
12.9 GlaxoSmithKline Plc
Exhibit 137: GlaxoSmithKline Plc - Overview
Exhibit 138: GlaxoSmithKline Plc - Business segments
Exhibit 139: GlaxoSmithKline Plc - Key offerings
Exhibit 140: GlaxoSmithKline Plc - Segment focus
12.10 Hologic Inc.
Exhibit 141: Hologic Inc. - Overview
Exhibit 142: Hologic Inc. - Business segments
Exhibit 143: Hologic Inc. - Key news
Exhibit 144: Hologic Inc. - Key offerings
Exhibit 145: Hologic Inc. - Segment focus
12.11 Inovio Pharmaceuticals Inc.
Exhibit 146: Inovio Pharmaceuticals Inc. - Overview
Exhibit 147: Inovio Pharmaceuticals Inc. - Product / Service
Exhibit 148: Inovio Pharmaceuticals Inc. - Key news
Exhibit 149: Inovio Pharmaceuticals Inc. - Key offerings
12.12 Johnson and Johnson
Exhibit 150: Johnson and Johnson - Overview
Exhibit 151: Johnson and Johnson - Business segments
Exhibit 152: Johnson and Johnson - Key news
Exhibit 153: Johnson and Johnson - Key offerings
Exhibit 154: Johnson and Johnson - Segment focus
12.13 Merck and Co. Inc.
Exhibit 155: Merck and Co. Inc. - Overview
Exhibit 156: Merck and Co. Inc. - Business segments
Exhibit 157: Merck and Co. Inc. - Key news
Exhibit 158: Merck and Co. Inc. - Key offerings
Exhibit 159: Merck and Co. Inc. - Segment focus
12.14 OK Biotech Co. Ltd.
Exhibit 160: OK Biotech Co. Ltd. - Overview
Exhibit 161: OK Biotech Co. Ltd. - Product / Service
Exhibit 162: OK Biotech Co. Ltd. - Key offerings
12.15 Priority STD Testing
Exhibit 163: Priority STD Testing - Overview
Exhibit 164: Priority STD Testing - Product / Service
Exhibit 165: Priority STD Testing - Key offerings
12.16 QIAGEN NV
Exhibit 166: QIAGEN NV - Overview
Exhibit 167: QIAGEN NV - Product / Service
Exhibit 168: QIAGEN NV - Key news
Exhibit 169: QIAGEN NV - Key offerings
12.17 RayBiotech Life Inc.
Exhibit 170: RayBiotech Life Inc. - Overview
Exhibit 171: RayBiotech Life Inc. - Product / Service
Exhibit 172: RayBiotech Life Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
AMC Entertainment Holdings, Inc. (the "Company," or "AMC"), today released preliminary results for the first quarter ended March 31, 2024. The preliminary results are unaudited, subject to completion of the Company's financial reporting processes,...
SolarBank Corporation (CBOE CA: SUNN) ("SolarBank" or the "Company") announces that it has partnered with TriMac Engineering of Sydney, Nova Scotia to develop a 10 MW DC community solar garden in the rural community of Enon, and three 7 MW DC...
As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the...
Tractor Beverage Company, one of North America's fastest-growing beverage brands and the first and only Certified Organic, non-GMO beverage company devoted to the food service industry, was named the winner of a Gold Stevie® Award in the Products in...
E-Textile Market is Segmented by Type (Passive Electronic Textiles, Active Electronic Textiles, Ultra-Electronic Textiles), by Application (Military Uses, Civil Uses, Healthcare Uses).
The Global E-Textile Market size is expected to reach USD 5238.3...
The Law Offices of Frank R. Cruz reminds investors of the upcoming April 29, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II...